Mpox-Specific Neutralizing Antibodies up to 9 Months Following 1 or 2 Doses of Intradermal MVA-BN Vaccination in Sweden. [PDF]
Espinosa-Gongora C +11 more
europepmc +1 more source
Monkeypox vaccine hesitancy among healthcare workers in Pakistan
Zahid Ali +9 more
openalex +1 more source
Sexual behaviors and associated factors among first-year undergraduates at overseas Chinese-oriented universities in China. [PDF]
Chen Z +5 more
europepmc +1 more source
Modeling Monkeypox dynamics with human–rodent interactions and waning vaccination
Turki D. Alharbi +3 more
openalex +1 more source
Monkeypox Virus Clade IIa Infections, Liberia, 2023-2024. [PDF]
Nyan DC +19 more
europepmc +1 more source
Potential Risk of Local Transmission of Mpox in Nepal: An Emerging Public Health Concern. [PDF]
Shah Y +9 more
europepmc +1 more source
Monkeypox Virus Transcriptional Profiles and Host Responses in Skin Lesion Swabs Among Individuals With Human Immunodeficiency Virus. [PDF]
Hurst JR +12 more
europepmc +1 more source
The dermatological manifestations and differential diagnosis of monkeypox: A narrative review
Jacob Al‐Dabbagh +3 more
openalex +1 more source
Sero-neutralizing antibody against orthopoxviruses in populations of Wuhan, China. [PDF]
Gao Z, Liu T, Zhao Z, Wang B, Hou L.
europepmc +1 more source
On the importance of communication, advocacy, and information accuracy in destigmatizing mpox disease. [PDF]
Hulland EN +4 more
europepmc +1 more source

